Hematopoietic stem cell transplantation in Egypt
H. K. Mahmoud(Cairo University), Almetwaly M. Sultan(Nasser Institute hospital), Mohamed Elemary(University of Saskatchewan), Amr Nassar(Jouf University), Mohamed Abdel-Mooti(Cairo University), Ali Sobhy(Nasser Institute hospital), Omar Fahmy(Washington University in St. Louis), Alaa Elhaddad(Cairo University)
Cited by 37
Related Papers
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
|The Lancet Haematology|2019|247
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
|Haematologica|2021|236
Ocular Findings after Allogeneic Hematopoietic Stem Cell Transplantation
|Ophthalmology|2009|141
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
|The Lancet Oncology|2021|134
Ocular manifestations of graft-versus-host disease
|Saudi Journal of Ophthalmology|2013|102